Daybreak joins Parachute Health, increasing access to therapy

LOS ANGELES – Daybreak has joined Parachute Health, creating a digital pathway that connects more than 300,000 clinicians and prescribers, 3,000 home medical equipment (HME) provider locations and 70,000 facilities and health systems nationwide using Parachute Health’s e-prescribing platform to Daybreak’s oral appliance therapy. "Obstructive sleep apnea remains widely underdiagnosed and undertreated in the United States, in part because the path from testing to treatment has historically been fragmented across multiple systems and providers," said Wesley Lones, founder and CEO of Daybreak. "By joining Parachute Health, it continues our broader mission to increase access to care, shorten time to treatment, and simplify a therapy pathway that has long been disjointed for both patients and the providers who treat them." For clinicians and prescribers using Parachute Health, they can now refer patients directly to Daybreak within the same e-prescribing workflow they already use for other HME orders. For HME providers, they can now use their established pathways within Parachute Health’s platform to request and receive prescriptions and clinical documentation to support patient therapies. Daybreak and Parachute Health say this shortens the time it takes to generate a valid, signed prescription, reducing the administrative burden that has historically slowed the path from sleep apnea diagnosis to treatment. “Parachute strives to decrease the friction between prescribers, HME providers and patients through our digital workflows,” said Rob Boeye, executive vice president, commercial leader, HME, at Parachute Health. “We are pleased to make Daybreak available to prescribers utilizing our platform.”

• Related: Daybreak expands access to oral appliance therapy for veterans.